The association between hormone therapy use and changes in strength and body composition in early postmenopausal women

Menopause

Volumn 11, Issue 4, 2004, Pages 438-446

  Maddalozzo, Gianni F ^a   Cardinal, Bradley J ^a   Li, Fuzhong ^b   Snow, Christine M ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON RESEARCH INSTITUTE   (United States)

Author keywords

Hormone therapy; Lean mass; Neuromuscular function; Postmenopausal women

Indexed keywords

ALENDRONIC ACID; CALCIUM; ESTROGEN; PROTEIN; VITAMIN D; CONJUGATED ESTROGEN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYNAMOMETRY; ENERGY EXPENDITURE; FEMALE; FEMUR NECK; HIP; HORMONAL THERAPY; HUMAN; LEAN BODY WEIGHT; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MUSCLE MASS; MUSCLE STRENGTH; NEUROMUSCULAR FUNCTION; POSTMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ADIPOSE TISSUE; DRUG EFFECT; LUMBAR VERTEBRA; MIDDLE AGED; PHYSIOLOGY; SKELETAL MUSCLE;

ADIPOSE TISSUE; BODY COMPOSITION; BONE DENSITY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HIP; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; MUSCLE, SKELETAL; POSTMENOPAUSE; PROSPECTIVE STUDIES;

EID: 4644324682     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000113847.74835.FE     Document Type: Article

References (42)

1. Nevitt MC, Cummings SR, Lane NE, et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1996;156:2073-2080.
2. Aloia JF, Vaswani A, Russo L, et al. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1991;172:896-900.
3. Tonkelaar ID, Seidell JC, van Noord PA, et al. E.A. Factors influencing waist/hip ratio in randomly selected pre- and postmenopausal women in the dom-project (preliminary results). Int J Obes 1989;13:817-824.
4. Philips SK, Rook KM, Siddle NC, et al. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clinical Science 1993;84:95-98.
5. Skelton DA, Phillips SK, Bruce SA, et al. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women. Clin Sci 1999;96:357-364.
6. Taaffe DR, Villa ML, Delay R, et al. Maximal muscle strength of elderly women is not influenced by oestrogen status. Age and Aging 1995;24:329-333.
7. Armstrong AL, Oborne J, Coupland CA, et al. Effects of hormone replacement therapy on muscle performance and balance in postmenopausal women. Clin Sci 1996;91:685-690.
8. Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998;6:246-254.
9. Haarbo J, Marslew U, Gotfredsen A, et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323.
10. Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. J Clin Endocrinol Metab 1997;82:1549-1556.
11. Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. Metabolism 1991;40:1323-1326.
12. Tonkelaar ID, Seidell JC, van Noord PA, et al. H.A. Factors influencing waist/hip ratio in randomly selected pre- and postmenopausal women in the dom-project (preliminary results). Int J Obes 1989;13:817-824.
13. Tchernof, A., J. Calles-Escandon, C.K. Sites, E.T. Poehlman. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 1998;9:503-511.
14. Aloia JF, Vaswani A, Ma R, et al. Comparative study of body composition by dual-energy x-ray absorptiometry. J Nucl Med 1995 36:1392-1397.
15. Bassey EJ, Short AH. A new method for measuring power output in a single leg extension: feasibility, reliability and validity. Eur J Appl Physiol 1990;60:385-390.
16. Blair SN, Ainsworth SN. The aerobics center longitudinal study physical activity questionnaire. Med Sci Sports Exerc 2002; 34(Suppl 6):S11-S14.
17. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;Suppl 9:S498-S504.
18. Block G. Block Food Questionnaire. Berkley, CA: National Cancer Institute, 1998.
19. Heaney RP. Protein intake and bone health: the influence of belief systems on the conduct of nutritional science. Am J Clin Nutr 2001; 73:5-6.
20. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D and Fluoride Washington, DC: National Academy Press, 1997.
21. Cardinal BJ. Effects of behavioral monitoring on physical activity and psychological determinants of exercise behavior. Soc Beh Person 1997;25:13-18.
22. Willett WC, Reynolds RO, Cottrell-Hoehner S, et al. Comparison of a semiquantitative food-questionnaire with one year diet record. J Amer Diet Assoc 1987;87:43-47.
23. Kendall FP, McCreary EK, Provance PG. In: Muscles: Testing and Function, 4th ed. Baltimore, MD: Williams and Wilkins, 1993.
24. Seeley DG, Cauley JA, Grady D, et al. Is post-menopuasal estrogen therapy associated with neuromuscular function or falling in elderly women? Arch. Intern Med 1995;155:293-299.
25. Timiras P. Physiological Basis of Geriatrics. New York, NY: Macmillian Publishing, 1988.
26. Larsson L, Grimby G, Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J of Appl Physio 1979;46:451-456.
27. Greeves JP, Cable NT, Reilly T, et al. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 1999;97:79-84.
28. Frost HM. Bone "mass" and the "mechanostat": a proposal. Anat Rec 1987;219:1-9.
29. Grabiner MD, Koh TJ, Lundin TM, et al. Kinematics of recovery from a stumble. J Gerontol 1993;48:M97-M102.
30. Widrick JJ, Maddalozzo GF, Lewis D, et al. Morphological and Functional Characteristics of Skeletal Muscle Fibers From Hormone-replaced and Nonreplaced Postmenopausal Women. J Gerontol A Biol Sci Med Sci 2003;58:3-10.
31. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal. Estrogen/Progestin Interventions (PEPI) Trial. JAMA 18;273:199-208.
32. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
33. Speroff L, Lobo RA. Postmenopausal hormone therapy and the cardiovascular system. Heart Dis Stroke 1994;3:173-176.
34. Poehlman ET, Toth MJ, Bunyard LB, et al. Physiological predictors of increasing total and central adiposity in aging men and women. Arch Intern Med 1995;155:2443-2448.
35. den Tonkelaar I, Seidell JC, van Noord PA, et al. Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross-sectional study in 11,825 Dutch women participating in the DOM-project. Int J Obes 1990;14:753-761.
36. Tchernof A J, Calles-Escandon J, Sites Ck, et al. Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Metabolism 1989;38:662-665.
37. Kritz-Silverstein D, and Barrett-Connor E. Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA 1996;275:46-49.
38. Poehlman ET, Toth MJ, Ades PA, et al. Gender differences in resting metabolic rate and noradrenaline kinetics in older individuals. Eur J Clin Invest 1997;27:23-28.
39. Poehlman ET, Toth MJ, Ades PA, et al. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997;27:322-326.
40. Sirola J, Kroger H, Honkanen R, Jurvelin JS, Sandini L, Tuppurainen MT, Saarikoski S (OSTPRE Study Group). Factors affecting bone loss around menopause in women without HRT: a prospective study. Maturitas 2003;45:159-167.
41. Vogel RA. The changing view of hormone replacement therapy. Rev Cardiovasc Med 2003;4:68-71.
42. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;25;289:3243-3253.